Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Resminostat hydrochloride | 1187075-34-8 | 99.7% | 385.87 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY14718A50MG

Encompass_Preferred

Resminostat hydrochloride is a potent inhibitor of HDAC1, HDAC3, and HDAC6 (IC50 values: 42.5, 50.1, 71.8 nM, respectively), and a less potent inhibitor of HDAC8 (IC50: 877 nM). It is for research use only.

  • Induces histone acetylation and inhibits myeloma cell growth.
  • Displays substrate competitive binding (Ki: 27 nM).
  • Modulates bcl-2 proteins and inhibits Akt pathway signalling.
  • Synergistic with other anti-myeloma agents.
  • Inhibits HNSCC cell growth (IC50s: 0.775-1.572 μM).
  • Synergistic effect with irradiation on HNSCC cells.
  • Reduces HCC cell viability with AZD-2014 co-treatment.

Catalog No. 50-003-59846


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.